These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25118649)

  • 1. Molecular docking studies of curcumin natural derivatives with DNA topoisomerase I and II-DNA complexes.
    Kumar A; Bora U
    Interdiscip Sci; 2014 Dec; 6(4):285-91. PubMed ID: 25118649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells.
    López-Lázaro M; Willmore E; Jobson A; Gilroy KL; Curtis H; Padget K; Austin CA
    J Nat Prod; 2007 Dec; 70(12):1884-8. PubMed ID: 18076140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Products as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases.
    Singh S; Pandey VP; Yadav K; Yadav A; Dwivedi UN
    Curr Protein Pept Sci; 2020; 21(11):1103-1142. PubMed ID: 32951576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
    Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
    Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular interactions of DNA-topoisomerase I and II inhibitor with DNA and topoisomerases and in ternary complexes: binding modes and biological effects for intoplicine derivatives.
    Nabiev I; Chourpa I; Riou JF; Nguyen CH; Lavelle F; Manfait M
    Biochemistry; 1994 Aug; 33(30):9013-23. PubMed ID: 8043587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, crystal structure and antiproliferative activity of Cu(II) nalidixic acid-DACH conjugate: comparative in vitro DNA/RNA binding profile, cleavage activity and molecular docking studies.
    Arjmand F; Yousuf I; Hadda Tb; Toupet L
    Eur J Med Chem; 2014 Jun; 81():76-88. PubMed ID: 24826817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II.
    Zhuo ST; Li CY; Hu MH; Chen SB; Yao PF; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
    Org Biomol Chem; 2013 Jun; 11(24):3989-4005. PubMed ID: 23657605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.
    Yao BL; Mai YW; Chen SB; Xie HT; Yao PF; Ou TM; Tan JH; Wang HG; Li D; Huang SL; Gu LQ; Huang ZS
    Eur J Med Chem; 2015 Mar; 92():540-53. PubMed ID: 25599951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative metabolites of curcumin poison human type II topoisomerases.
    Ketron AC; Gordon ON; Schneider C; Osheroff N
    Biochemistry; 2013 Jan; 52(1):221-7. PubMed ID: 23253398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative Transformation of Demethoxy- and Bisdemethoxycurcumin: Products, Mechanism of Formation, and Poisoning of Human Topoisomerase IIα.
    Gordon ON; Luis PB; Ashley RE; Osheroff N; Schneider C
    Chem Res Toxicol; 2015 May; 28(5):989-96. PubMed ID: 25806475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
    Thapa U; Thapa P; Karki R; Yun M; Choi JH; Jahng Y; Lee E; Jeon KH; Na Y; Ha EM; Cho WJ; Kwon Y; Lee ES
    Eur J Med Chem; 2011 Aug; 46(8):3201-9. PubMed ID: 21601964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salicylate, a catalytic inhibitor of topoisomerase II, inhibits DNA cleavage and is selective for the α isoform.
    Bau JT; Kang Z; Austin CA; Kurz EU
    Mol Pharmacol; 2014 Feb; 85(2):198-207. PubMed ID: 24220011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 dependence of topoisomerase I recruitment in vivo.
    Mao Y; Okada S; Chang LS; Muller MT
    Cancer Res; 2000 Aug; 60(16):4538-43. PubMed ID: 10969804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants of the catalytic inhibition of human topoisomerase IIα by salicylate analogs and salicylate-based drugs.
    Bau JT; Kurz EU
    Biochem Pharmacol; 2014 Jun; 89(4):464-76. PubMed ID: 24695359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cells lacking DNA topoisomerase II beta are resistant to genistein.
    López-Lazaro M; Willmore E; Austin CA
    J Nat Prod; 2007 May; 70(5):763-7. PubMed ID: 17411092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-chloromethylene-6-fluorothiochroman-4-one, A novel DNA Topoisomerase poison.
    Wang Y; Chen J; Shen R; Yang C; Ma Z; Liu Y
    Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2377-2383. PubMed ID: 28167481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
    My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ
    Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topoisomerase I and IIalpha protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy.
    Tsavaris N; Lazaris A; Kosmas C; Gouveris P; Kavantzas N; Kopterides P; Papathomas T; Agrogiannis G; Zorzos H; Kyriakou V; Patsouris E
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):391-8. PubMed ID: 19083133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green tea constituents (-)-epigallocatechin-3-gallate (EGCG) and gallic acid induce topoisomerase I- and topoisomerase II-DNA complexes in cells mediated by pyrogallol-induced hydrogen peroxide.
    López-Lázaro M; Calderón-Montaño JM; Burgos-Morón E; Austin CA
    Mutagenesis; 2011 Jul; 26(4):489-98. PubMed ID: 21382914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase IIα, rather than IIβ, is a promising target in development of anti-cancer drugs.
    Chen W; Qiu J; Shen YM
    Drug Discov Ther; 2012 Oct; 6(5):230-7. PubMed ID: 23229142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.